Sphingosine-1-phosphate receptor subtype 1 activation in the central nervous system contributes to morphine withdrawal in rodents

Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management

(2020) Joseph V. Pergolizzi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Ozanimod: First Approval

(2020) Yvette N. Lamb   DRUGS

GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents

(2020) Gina L.C. Yosten et al.   JOURNAL OF CLINICAL INVESTIGATION

Activation of sphingosine-1-phosphate receptor subtype 1 in the central nervous system contributes to morphine-induced hyperalgesia and antinociceptive tolerance in rodents

(2020) Timothy M. Doyle et al.   PAIN

Activation of Sphingosine-1-Phosphate Receptor 1 in the Spinal Cord Produces Mechanohypersensitivity Through the Activation of Inflammasome and IL-1β Pathway

(2019) Timothy M. Doyle et al.   JOURNAL OF PAIN

Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia and Negative Reinforcement

(2019) George F. Koob   BIOLOGICAL PSYCHIATRY

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence

(2019) Kelly E Dunn et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Glial neuroimmune signaling in opioid reward

(2019) Hong Zhang et al.   BRAIN RESEARCH BULLETIN

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain

(2018) Katherine Stockstill et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Differential Spinal and Supraspinal Activation of Glia in a Rat Model of Morphine Tolerance

(2018) Viljami Jokinen et al.   NEUROSCIENCE

Glial mechanisms underlying substance use disorders

(2018) K.E. Linker et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Neuroimmune mechanisms of psychostimulant and opioid use disorders

(2018) Rebecca S. Hofford et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Sphingolipids and their metabolism in physiology and disease

(2017) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems

(2016) Luke Healy et al.   CURRENT DRUG TARGETS

ORMDL proteins regulate ceramide levels during sterile inflammation

(2016) Lin Cai et al.   JOURNAL OF LIPID RESEARCH

Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies

(2016) Nora D. Volkow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Opioid-Induced Central Immune Signaling: Implications for Opioid Analgesia

(2015) Peter M. Grace et al.   HEADACHE

The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1

(2014) Kali Janes et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sphingolipid metabolites in inflammatory disease

(2014) Michael Maceyka et al.   NATURE

Endogenous Interleukin-1β in Neuropathic Rats Enhances Glutamate Release from the Primary Afferents in the Spinal Dorsal Horn through Coupling with PresynapticN-Methyl-d-aspartic Acid Receptors

(2013) Xisheng Yan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy

(2013) Aran Groves et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond

(2013) Gregory T. Kunkel et al.   NATURE REVIEWS DRUG DISCOVERY

Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain

(2013) Daniela Salvemini et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Sphingosine-1-phosphate receptors as emerging targets for treatment of pain

(2012) Sandra P. Welch et al.   BIOCHEMICAL PHARMACOLOGY

An Oral Sphingosine 1-Phosphate Receptor 1 (S1P1) Antagonist Prodrug with Efficacy in Vivo: Discovery, Synthesis, and Evaluation

(2012) Daniela Angst et al.   JOURNAL OF MEDICINAL CHEMISTRY

Role of P2X7 Receptor-Mediated IL-18/IL-18R Signaling in Morphine Tolerance: Multiple Glial-Neuronal Dialogues in the Rat Spinal Cord

(2012) Meng-Ling Chen et al.   JOURNAL OF PAIN

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Morphine activates neuroinflammation in a manner parallel to endotoxin

(2012) X. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strains

(2011) Liang Liu et al.   BRAIN BEHAVIOR AND IMMUNITY

Amelioration of Collagen-Induced Arthritis by a Novel S1P1 Antagonist with Immunomodulatory Activities

(2011) Y. Fujii et al.   JOURNAL OF IMMUNOLOGY

Exploring the Neuroimmunopharmacology of Opioids: An Integrative Review of Mechanisms of Central Immune Signaling and Their Implications for Opioid Analgesia

(2011) M. R. Hutchinson et al.   PHARMACOLOGICAL REVIEWS

Kdo2-Lipid A, a TLR4-specific Agonist, Inducesde NovoSphingolipid Biosynthesis in RAW264.7 Macrophages, Which Is Essential for Induction of Autophagy

(2010) Kacee Sims et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Cellular Localization of Sphingosine-1-phosphate Receptor 1 Expression in the Human Central Nervous System

(2010) Hirotake Nishimura et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Counter-Regulation of Opioid Analgesia by Glial-Derived Bioactive Sphingolipids

(2010) C. Muscoli et al.   JOURNAL OF NEUROSCIENCE

Spinal Matrix Metalloproteinase-9 Contributes to Physical Dependence on Morphine in Mice

(2010) W.-T. Liu et al.   JOURNAL OF NEUROSCIENCE

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

(2010) Volker Brinkmann et al.   NATURE REVIEWS DRUG DISCOVERY

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

(2009) Mark R. Hutchinson et al.   BRAIN BEHAVIOR AND IMMUNITY

μ-Opioid receptor-stimulated synthesis of reactive oxygen species is mediated via phospholipase D2

(2009) Thomas Koch et al.   JOURNAL OF NEUROCHEMISTRY

Morphine Enhances Microglial Migration through Modulation of P2X4 Receptor Signaling

(2009) R. J. Horvath et al.   JOURNAL OF NEUROSCIENCE

The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia

(2009) Linda R. Watkins et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)

(2008) Mark R. Hutchinson et al.   BRAIN BEHAVIOR AND IMMUNITY

A synergistic role for IL-1β and TNFα in monocyte-derived IFNγ inducing activity

(2008) Raquel M. Raices et al.   CYTOKINE

Interleukin-1β-dependent Signaling between Astrocytes and Neurons Depends Critically on Astrocytic Calcineurin/NFAT Activity

(2008) Michelle A. Sama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

"Inside-Out" Signaling of Sphingosine-1-Phosphate: Therapeutic Targets

(2008) K. Takabe et al.   PHARMACOLOGICAL REVIEWS